Sale!

PMP22 Gene CMT1A Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PMP22 Gene CMT1A NGS Genetic DNA Test is a comprehensive genetic screening test that detects mutations in the PMP22 gene responsible for Charcot-Marie-Tooth disease type 1A. This advanced next-generation sequencing test provides accurate diagnosis for individuals experiencing peripheral neuropathy symptoms, muscle weakness, and sensory loss. The test helps identify inherited neurological conditions, enabling proper treatment planning and genetic counseling. With results available in 3-4 weeks, this test offers crucial insights for patients and families affected by hereditary neuropathies. The test costs $500 USD and requires a blood sample or extracted DNA.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PMP22 Gene CMT1A NGS Genetic DNA Test

Comprehensive Genetic Testing for Charcot-Marie-Tooth Disease Type 1A

The PMP22 Gene CMT1A NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with Charcot-Marie-Tooth disease type 1A. This advanced genetic screening utilizes next-generation sequencing technology to provide comprehensive analysis of the PMP22 gene, which plays a critical role in peripheral nerve function and myelination.

What Does This Test Measure?

This sophisticated genetic test specifically targets and analyzes the PMP22 (Peripheral Myelin Protein 22) gene for:

  • Detection of PMP22 gene duplications responsible for CMT1A
  • Identification of point mutations and deletions in the PMP22 gene
  • Comprehensive analysis of gene copy number variations
  • Assessment of genetic variants affecting peripheral nerve function
  • Evaluation of hereditary neuropathy predisposition

Who Should Consider This Test?

This genetic screening is recommended for individuals experiencing:

  • Progressive muscle weakness in feet and hands
  • Foot deformities such as high arches or hammertoes
  • Decreased sensation or numbness in extremities
  • Difficulty with balance and coordination
  • Family history of peripheral neuropathy
  • Unexplained muscle atrophy in lower limbs
  • Delayed motor development in children
  • Symptoms consistent with hereditary neuropathies

Key Benefits of PMP22 Genetic Testing

  • Accurate Diagnosis: Provides definitive identification of CMT1A genetic mutations
  • Family Planning: Enables informed reproductive decisions for affected families
  • Early Intervention: Facilitates timely management and treatment planning
  • Symptom Management: Guides appropriate therapeutic interventions
  • Genetic Counseling: Supports comprehensive family risk assessment
  • Disease Progression Monitoring: Establishes baseline for ongoing care

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and neurologists:

  • Positive Result: Indicates presence of PMP22 gene mutation consistent with CMT1A diagnosis
  • Negative Result: Suggests absence of detectable PMP22 mutations, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
  • Carrier Status: Determines inheritance patterns for family members

All results include comprehensive genetic counseling to ensure proper understanding and appropriate next steps for medical management.

Test Details and Pricing

Test Component Details
Test Name PMP22 Gene CMT1A NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before scheduling your PMP22 genetic test, we recommend:

  • Comprehensive clinical history documentation
  • Genetic counseling session to discuss testing implications
  • Development of detailed family pedigree chart
  • Neurological examination and assessment
  • Discussion of potential outcomes and management options

Nationwide Testing Availability

GGC DNA provides comprehensive genetic testing services across the United States, with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of testing location.

Take Control of Your Neurological Health

Don’t let uncertainty about hereditary neuropathy symptoms affect your quality of life. The PMP22 Gene CMT1A NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management of Charcot-Marie-Tooth disease. Our team of genetic specialists and neurologists are ready to support you through every step of the testing process.

Ready to schedule your genetic test? Contact our genetic counseling team today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your neurological health with confidence and precision.